BIM

114.2

+0.79%↑

SRT3

229.2

+0.26%↑

GXI

54

+3.75%↑

ICAD

21.06

-1.5%↓

BIM

114.2

+0.79%↑

SRT3

229.2

+0.26%↑

GXI

54

+3.75%↑

ICAD

21.06

-1.5%↓

BIM

114.2

+0.79%↑

SRT3

229.2

+0.26%↑

GXI

54

+3.75%↑

ICAD

21.06

-1.5%↓

BIM

114.2

+0.79%↑

SRT3

229.2

+0.26%↑

GXI

54

+3.75%↑

ICAD

21.06

-1.5%↓

BIM

114.2

+0.79%↑

SRT3

229.2

+0.26%↑

GXI

54

+3.75%↑

ICAD

21.06

-1.5%↓

Search

Fresenius Medical Care AG

Closed

SectorHealthcare

42.5 1.5

Overview

Share price change

24h

Current

Min

41.86

Max

42.8

Key metrics

By Trading Economics

Income

-146M

67M

Sales

325M

5.1B

P/E

Sector Avg

21.17

57.333

EPS

0.82

Dividend yield

3.19

Profit margin

1.316

EBITDA

-19M

811M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+8.2% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

3.19%

2.63%

Next Earnings

6 maj 2025

Market Stats

By TradingEconomics

Market Cap

1.6B

16B

Previous open

41

Previous close

42.5

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Fresenius Medical Care AG Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

21 mar 2025, 08:19 UTC

Market Talk

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

25 lut 2025, 10:27 UTC

Market Talk
Earnings

Fresenius Medical Care's U.S. Volume Growth Is Unlikely to Reassure Investors -- Market Talk

15 lip 2024, 08:17 UTC

Market Talk

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

3 maj 2024, 08:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Fresenius' Disposal of Part of Its Rehabilitation Business Seems Positive -- Market Talk

Peer Comparison

Price change

Fresenius Medical Care AG Forecast

Price Target

By TipRanks

8.2% upside

12 Months Forecast

Average 45.54 EUR  8.2%

High 55 EUR

Low 37 EUR

Based on 14 Wall Street analysts offering 12 month price targets forFresenius Medical Care AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

14 ratings

3

Buy

8

Hold

3

Sell

Technical Score

By Trading Central

41.58 / 42.11Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Very Strong Bearish Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Fresenius Medical Care AG

Fresenius Medical Care AG & Co. KGaA